{"id":553349,"title":"Regulatory roadmap for radiopharmaceutical (Schedule C) drugs in Canada - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T02:40:34.051000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-roadmap-schedule-c.html","snippet":"Regulatory roadmap for radiopharmaceutical (Schedule C) drugs in Canada From Health Canada This regulatory roadmap gives comprehensive, general information about the regulation of radiopharmaceutical drugs for human use in Canada. All drugs marketed in Canada are subject to the…","rawSnapshotUrl":"/api/snapshots/raw/553349","browseUrl":"https://replay.healtharchive.ca/job-6/20260306024034/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-roadmap-schedule-c.html#ha_snapshot=553349","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}